$NSPR This one needs a few PRs, they can easily make this fly with the right PRs. This company has a lot of potential. If they play their PR card right, this will easily fly. (Check their 12 months publication, CGAURD trial, FDA submissions and their investor presentation)
  • 3
3 Likes